new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Amgen Fremont Inc patents

Recent patent applications related to Amgen Fremont Inc. Amgen Fremont Inc is listed as an Agent/Assignee. Note: Amgen Fremont Inc may have other listings under different names/spellings. We're not affiliated with Amgen Fremont Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Amgen Fremont Inc-related inventors




Date Amgen Fremont Inc patents (updated weekly) - BOOKMARK this page
02/23/17Antibodies to madcam
10/27/16Antibodies directed to gpnmb and uses thereof
08/25/16Antibodies to m-csf
06/02/16Antibodies to cd40
04/07/16Antibodies to insulin-like growth factor i receptor
11/05/15Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
09/24/15Antibodies to opgl
09/10/15Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
07/16/15Psma antibodies and uses thereof
04/16/15Human monoclonal antibodies to ctla-4
02/12/15Antibodies directed to gpnmb and uses thereof
09/25/14Psma antibodies and uses thereof
05/01/14Antibodies to insulin-like growth factor i receptor
04/17/14High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies
03/27/14Treatment methods using c-met antibodies
12/26/13Reducing the risk of human anti-human antibodies through v gene manipulation
01/24/13Antibodies to cd40
12/20/12Antibodies to c-met
09/27/12Antibodies to m-csf
09/06/12Antibodies to cd40
08/30/12Reducing the risk of human anti-human antibodies through v gene manipulation
06/14/12Human monoclonal antibodies to ctla-4
03/01/12Human monoclonal antibodies to activin receptor-like kinase-1
03/01/12Modulation of the vps10p-domain receptor family for the treatment of mental and behavioural disorders
01/05/12Antibodies to insulin-like growth factor i receptor
03/17/11Anti ige antibodies
12/02/10Human monoclonal antibodies to epidermal growth factor receptor
07/22/10Antibodies against interleukin-1 beta
05/06/10Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
02/04/10Reducing the risk of human anti-human antibodies through v gene manipulation
09/24/09Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
09/24/09Polypeptide fusion
07/09/09Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
06/18/09Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
06/18/09Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Amgen Fremont Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Amgen Fremont Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';